Subureteral Injection with Small-Size Dextranomer/Hyaluronic Acid Copolymer: Is It Really Efficient?

Table 1

The demographic features of patients.

	The degree of VUR before treatment
	Grade 1 (: 1)	Grade 2 (: 9)	Grade 3 (: 38)	Grade 4 (: 27)
Age (mean)	11	7,1 (2–14)	7,1 (1–12)	5,5 (1–12)	0,155
Follow-up (months)	20	21,8 (5–48)	10,8 (1–36)	9,8 (1–40)	0,012
Sex
Male (: 19)	0	3 (4%)	6 (8%)	10 (13,3%)	0,219
Female (: 56)	1 (1,3%)	6 (8%)	32 (42,7%)	17 (22,7%)
VUR side
Left	0	3 (4%)	12 (16%)	6 (8%)	0,077
Right	1 (1,3%)	6 (8%)	10 (13,3%)	7 (9,3%)
Bilateral	0	0	16 (21,3%)	14 (18,7%)
Treatment indication
Infection	1 (1,3%)	9 (12%)	22 (29,3%)	15 (20%)	0,075
Scar	0	0	16 (21,3%)	12 (16%)